Sunshine Global Circuits
300739
Guangdong Brandmax Marketing
300805
Shengyi Electronics
688183
ZECHENG ELECTRONICS
837821
Jiangsu Jinling Sports Equipment
300651
CN Stock MarketDetailed Quotes
002750 Kunming Longjin Pharmaceutical
- 2.57
- -0.13-4.81%
Market Closed Dec 17 15:00 CST
1.03BMarket Cap-19.18P/E (TTM)
2.73High2.57Low107.94KlotVolume2.72Open2.70Pre Close28.13MTurnover2.71%Turnover RatioLossP/E (Static)400.50MShares11.5052wk High2.05P/B1.02BFloat Cap1.4352wk Low2.84Limit Up398.74MShs Float26.32Historical High2.57Limit Down5.93%Amplitude1.43Historical Low--Dividend TTM2.61Avg Price69.47KlotAsk--Div YieldTTM100Lot Size37.96KlotBid
Kunming Longjin Pharmaceutical News
*ST Longjin: Announcement on Additional Provisional Proposals and Supplementary Notices for the 2024 Second Extraordinary General Meeting of Shareholders
*ST Longjin: Notice on Using Idle Own Funds for Cash Management
*ST Longjin: Notice of the 2024 Second Extraordinary General Meeting of Shareholders
*ST Longjin: Announcement on the holding subsidiary obtaining a drug registration certificate
*ST Longjin: Semi-annual summary of non-operating capital expenditure and other related capital transactions
Kunming Longjin Pharmaceutical: Notice of Response to the 2023 Annual Report Inquiry Letter
Kunming Longjin Pharmaceutical: 2023 Annual General Meeting of Shareholders Legal Opinions
Kunming Longjin Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Kunming Longjin Pharmaceutical: Summary report of the Board Audit Committee on the evaluation of the accounting firm's performance in 2023
Kunming Longjin Pharmaceutical: Special instructions on the proposed non-distribution of profits in 2023
Kunming Longjin Pharmaceutical: 2023 Financial Results Report
Kunming Longjin Pharmaceutical: Announcement on delisting risk warning and suspension of trading of the company's stock trading
Kunming Longjin Pharmaceutical: Internal Control Self-Assessment Report
Kunming Longjin Pharmaceutical: Notice of Annual General Meeting of Shareholders
Kunming Longjin Pharmaceutical: Notice on Accruing Asset Impairment Preparation and Credit Impairment Preparation
Longjin Pharmaceutical: An indicative announcement on the risk of delisting risk of the company's stock transactions
Longjin Pharmaceutical: Progress Announcement on Using Idle Own Funds for Cash Management
Longjin Pharmaceutical: Progress Announcement on Using Idle Own Funds for Cash Management
Longjin Pharmaceutical: Progress Announcement on Using Idle Own Funds for Cash Management
Longjin Pharmaceutical: An indicative announcement on the risk of delisting risk of the company's stock transactions
